Study Says New TB Vaccines Could Save 7.3 Million Lives
New tuberculosis vaccines expected from 2029 could save more than 7 million lives over two decades, Gavi said on Monday, … Read More The post Study Says New TB Vaccines Could Save 7.3 Million Lives appeared first on ProPakistani .
New tuberculosis vaccines, anticipated to arrive in 2029, could potentially save up to 7.3 million lives between 2030 and 2050, according to a new analysis. This breakthrough could yield an economic benefit of up to US$135 billion for low- and middle-income nations. Gavi, the Vaccine Alliance, emphasizes the urgency of preparedness for these vaccines' arrival, projecting demand for vaccination courses of up to 86 million annually, primarily in high-burden countries.
Dr. Sania Nishtar, CEO of Gavi, underscores the importance of securing affordable and predictable supply for countries with the highest disease burden. Currently, the Bacille Calmette-Guérin (BCG) vaccine is the only licensed option, but its protective efficacy diminishes over time, underscoring the need for newer vaccines targeting adolescents and adults.
While new candidates may receive regulatory approval by the end of the decade, challenges such as policy, financing, and supply risks could hinder their rapid rollout. To mitigate these risks, Gavi outlines three objectives: ensuring supply, promoting uptake, and fostering a diverse vaccine pipeline. Meanwhile, high-burden countries are already preparing for vaccine availability.
Written by urgent.news from AllAfrica Health's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
